# Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

> **NCT00460408** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 501 (actual)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Macugen

## Key facts

- **NCT ID:** NCT00460408
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460408, "Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00460408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*